In vitro activities of caspofungin and ketoconazole against Iranian isolates of Candida albicans

被引：0
|
作者：
Abad, H. Shekari Ebrahim [1 ]
Zaini, F. [1 ]
Kordbacheh, P. [1 ]
Mahmoudi, M. [2 ]
Safara, M. [1 ]
Mortezaee, V. [1 ]
机构：
[1] Tehran Univ Med Sci &, Sch Publ Hlth, Dept Mycol & Parasitol, Tehran, Iran
[2] Tehran Univ Med Sci & Tehran, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2012年 / 16卷
关键词：
D O I：
10.1016/j.ijid.2012.05.376
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E327 / E327
页数：1
相关论文
共 50 条
  • [1] In vitro activity of caspofungin against Candida albicans biofilms
    Bachmann, SP
    VandeWalle, K
    Ramage, G
    Patterson, TF
    Wickes, BL
    Graybill, JR
    López-Ribot, JL
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) : 3591 - 3596
  • [2] In vitro activities of terbinafine against cutaneous isolates of Candida albicans and other pathogenic yeasts
    Ryder, NS
    Wagner, S
    Leitner, I
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) : 1057 - 1061
  • [3] COMPARISON OF MICONAZOLE AND KETOCONAZOLE ACTIVITIES AGAINST CANDIDA-ALBICANS AND CANDIDA-PARAPSILOSIS
    BEGGS, WH
    IRCS MEDICAL SCIENCE-BIOCHEMISTRY, 1982, 10 (09): : 748 - 749
  • [4] Development and In Vitro Assessment of Nanoemulsion for Delivery of Ketoconazole Against Candida albicans
    De Campos, V. E. B.
    Cerqueira-Coutinho, C. S.
    Capella, F. N. C.
    Soares, B. G.
    Holandino, C.
    Mansur, C. R. E.
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2017, 17 (07) : 4623 - 4630
  • [5] In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata
    Oliveira, ER
    Fothergill, AW
    Kirkpatrick, WR
    Coco, BJ
    Patterson, TF
    Redding, SW
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) : 3544 - 3545
  • [6] In Vitro Study of Sequential Fluconazole and Caspofungin Treatment against Candida albicans Biofilms
    Sarkar, Semanti
    Uppuluri, Priya
    Pierce, Christopher G.
    Lopez-Ribot, Jose L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 1183 - 1186
  • [7] Biomarkers of caspofungin resistance in Candida albicans isolates: A proteomic approach
    De Cesare, Giuseppe Buda
    Hafez, Ahmed
    Stead, David
    Llorens, Carlos
    Munro, Carol A.
    VIRULENCE, 2022, 13 (01) : 1005 - 1018
  • [8] In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility
    Cota, Jason
    Carden, Michael
    Graybill, John R.
    Najvar, Laura K.
    Burgess, David S.
    Wiederhold, Nathan P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (11) : 3926 - 3928
  • [9] In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance
    Bachmann, SP
    Patterson, TF
    López-Ribot, JL
    JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) : 2228 - 2230
  • [10] In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles
    Barchiesi, F
    DiFrancesco, LF
    Scalise, G
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (08) : 1812 - 1814
12345